Alimentiv

Industry-leading specialty GI contract research organization (CRO) transforming clinical trial outcomes and accelerating the development of life-changing therapies. We bring together deep GI expertise, advanced medical imaging solutions, clinical operation excellence and cutting-edge precision medicine/laboratory services. With a global network of 5,000+ sites in >60 countries and growing, we expedite study activation and maximize patient enrollment, ensuring efficient and impactful clinical trials. Trusted by pharmaceutical and biotech partners, we support over 70% of all IBD compounds in development today – delivering customized end-to-end solutions to bring novel therapies to market. As a full-service CRO, our offering is tailored to meet your specific clinical research needs: • Clinical Trial Services • Medical Monitoring • Medical Imaging Solutions • Medical Research & Development • Medical Writing • Precision Medicine/Biomarkers • Clinical Pharmacology • Histopathology via Specialty Lab, AcelaBio • Spatial Biology • Statistics • Real-World Evidence Headquartered in London, Ontario, Alimentiv operates with globally across Canada, the US, Europe, Asia-Pacific, and Latin America.